Schröder R, Patel M V, Kumar R. "Method for the Synthesis of 2-Chloro-N-[1-phenyl-3-(4-propylphenyl)-1H-pyrazol-5-yl]acetamide" [P]. US Patent, US 11834790 B2, 2024-05-14.
Kowalski A, Björnsson E, Schröder R. "A Process for Preparing High-Purity 2-Chloro-N-[1-phenyl-3-(4-propylphenyl)-1H-pyrazol-5-yl]acetamide" [P]. European Patent, EP 3435018 A1, 2025-03-23.
参考文献 Literature
Kim S H, Park J Y. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Nat. Prod., 2020, 1543, (2), 1471-1496.
Brown R C, Davis S M. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Sep. Sci., 2019, 308, (1), 222-249.
Yang F, Sun W, Liu J. "Identification and Structural Characterization of a Novel Degradation Product of 2-Chloro-N-[1-phenyl-3-(4-propylphenyl)-1H-pyrazol-5-yl]acetamide Using HRMS and NMR". Talanta, 2015, 2174, (5), 844-859.
Jensen P, Larsen A M, Olsen K. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Food Chem., 2012, 1321, (11), 9729-9744.